pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Nanoscope Therapeutics Inc

updated 3mo ago
Website ↗
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Preclinical: 1Phase 3: 1
1Preclinical1Phase 3
Phase 3
sonpiretigene isteparvovec
Retinitis Pigmentosa (Retinitis)
Preclinical
NOD-800
Geographic Atrophy

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • —A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injectionenrolling by invitationn=11
  • —Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Studyactive not recruitingn=18
  • —A Prospective Observational Study to Assess the Reliability and Validity of the MLSDTrecruitingn=30
  • —Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Studyactive not recruitingn=6
  • phase2Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]completedn=27
  • —Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDTcompletedn=35
  • phase2Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Diseasecompletedn=6
🐶 Hiring Signal
No open roles indexed yet — view Nanoscope Therapeutics Inc jobs →

News

  • ‘We’re making a lot of progress’: How Nobel-winning optogenetics is being harnessed by biotechs
    As a notorious night owl, it was already very early in the morning of October 5 when Karl Deisseroth, M.D., Ph.D., finally laid down to get some shuteye. Not long after, the phone of the Stanford p…
    fiercebiotech · 1mo ago
  • Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or Medicine
    The 2026 Nobel Prize in Physiology or Medicine has been awarded to three scientists who forged a new neuroscience technique that uses light to precisely flip chosen neurons on and off.
    fiercebiotech · 1mo ago
identifiers
source
globaldata
top tags
Ophthalmology2AMD1
mentioned in
2news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?